Abstract
In the current study; it was tried to determine antiproliferative activity of extract obtained from Cistus laurifolius leaves on different cancer cell type such as human cervical adenocarcinoma cells (Hep2C), human muscle rhabdomyosarcoma cells (RD), mouse fibrosarcoma cells (Wehi 164) by MTT Assay. The results indicated that Cistus laurifolius inhibited, in a dose-dependent manner, the proliferation of Hep2C, RD, Wehi 164 cells. Maximum anti-proliferatif effects were observed in 1000 µg/ml, 500 µg/ml, 250µg/ml concentrations of extract. These findings suggest that Cistus laurifolius extract could reduce proliferatif effect of cancer cell lines. Their use as potential anticancer agent needs further studies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
